Benitec Biopharma Inc (BNTC)

SG&A Expenses

$6.54M

Quarterly · Period ending: · USD

BNTC logo

BNTC SG&A Expenses

Latest reported$6.54M
BNTC Quarterly SG&A Expenses ($875.10K → $6.54M)
High-resolution chart · PNG

BNTC sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Benitec Biopharma Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
6,544,000
7,284,000
7,543,000
6,433,000
13,481,000
8,840,000
5,420,000
2,206,000
2,036,000
1,578,000
1,824,000
1,551,000
1,371,000
1,228,000
1,863,000
1,920,000
1,553,000
1,337,000
1,714,000
2,042,000
1,536,000
1,029,000
2,111,000
1,837,000
1,898,000
2,119,324
2,690,548
1,113,763
1,230,043
1,553,814
1,216,307
2,428,057
1,044,973
1,252,043
1,262,978
1,348,878
1,277,252
1,453,591
1,257,486
1,280,313
1,203,213
1,726,026
2,331,178
1,331,736
2,581,623
1,767,061
1,821,983
1,912,854
1,304,336
1,302,105
988,503
1,095,967
874,660
880,859
882,893
875,101
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.